Physician profile
Daniel Carothers
NPI 1730116161
$7,992.76
in general payments reported to CMS, 2019-2025
19 companies · $956 in 2025
The $956 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,194 · 2020: $398 · 2021: $680 · 2022: $414 · 2023: $630 · 2024: $721 · 2025: $956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,307.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $4,102.50 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,010.23 | 2019-2025 | Dupixent |
| Genzyme Corporation | $895.81 | 2020-2025 | |
| Stryker Corporation | $731.73 | 2019-2024 | Xpress Loprofile |
| Intersect Ent, INC. | $206.73 | 2019-2021 | |
| Kaleo, INC. | $174.70 | 2019-2024 | Auvi-Q |
| Glaxosmithkline, LLC. | $170.44 | 2024-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $144.07 | 2025 | Tezspire |
| Inspire Medical Systems, INC. | $126.02 | 2023-2025 | Inspire |
| Aerin Medical INC. | $99.64 | 2019-2024 | |
| Hikma Pharmaceuticals USA | $91.00 | 2023-2025 | Ryaltris |
| Spirair, INC. | $40.03 | 2024 | Septalign |
| Alk-Abello, INC | $34.87 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $34.75 | 2019 | |
| Amgen INC. | $34.39 | 2025 | Tezspire |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $26.52 | 2025 | Neffy |
| Integra Lifesciences Corporation | $24.78 | 2023 | Codman Isocool Aht, Integra Duo, Microfrance |
| Paratek Pharmaceuticals, INC. | $24.35 | 2025 | Xhance |
| Fortovia Therapeutics, INC. | $20.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Carothers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.